These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 28859784)
41. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. Desai AS; Fang JC; Maisel WH; Baughman KL JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919 [TBL] [Abstract][Full Text] [Related]
42. Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale. Taborsky M; Skala T; Aiglova R; Fedorco M; Kautzner J; Jandik T; Vancura V; Linhart A; Valek M; Novak M; Kala P; Polasek R; Roubicek T; Schee A; Hindricks G; Dagres N; Hatala R; Jarkovsky J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):173-179. PubMed ID: 33724264 [TBL] [Abstract][Full Text] [Related]
43. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
44. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate. Barra S; Boveda S; Providência R; Sadoul N; Duehmke R; Reitan C; Borgquist R; Narayanan K; Hidden-Lucet F; Klug D; Defaye P; Gras D; Anselme F; Leclercq C; Hermida JS; Deharo JC; Looi KL; Chow AW; Virdee M; Fynn S; Le Heuzey JY; Marijon E; Agarwal S; J Am Coll Cardiol; 2017 Apr; 69(13):1669-1678. PubMed ID: 28359511 [TBL] [Abstract][Full Text] [Related]
45. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962 [TBL] [Abstract][Full Text] [Related]
46. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology. Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420 [TBL] [Abstract][Full Text] [Related]
47. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954 [TBL] [Abstract][Full Text] [Related]
49. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). Buber J; Goldenberg I; Moss AJ; Wang PJ; McNitt S; Hall WJ; Eldar M; Barsheshet A; Shechter M J Am Coll Cardiol; 2012 Aug; 60(8):749-55. PubMed ID: 22703927 [TBL] [Abstract][Full Text] [Related]
50. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study. Taylor RJ; Umar F; Panting JR; Stegemann B; Leyva F Heart Rhythm; 2016 Feb; 13(2):481-9. PubMed ID: 26498258 [TBL] [Abstract][Full Text] [Related]
51. Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial. Wilton SB; Exner DV; Wyse DG; Yetisir E; Wells G; Tang AS; Healey JS Circ Arrhythm Electrophysiol; 2016 May; 9(5):. PubMed ID: 27162033 [TBL] [Abstract][Full Text] [Related]
52. Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis. Barra S; Providência R; Duehmke R; Boveda S; Begley D; Grace A; Narayanan K; Tang A; Marijon E; Agarwal S Europace; 2018 Mar; 20(3):481-491. PubMed ID: 28666319 [TBL] [Abstract][Full Text] [Related]
53. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT). Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576 [TBL] [Abstract][Full Text] [Related]
54. Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of MADIT-CRT defined by baseline conduction and 1-year post-treatment left ventricular remodeling. Goldstein RE; Haigney MC; Krone RJ; McNitt S; Zareba W; Moss AJ Heart Rhythm; 2013 Mar; 10(3):366-73. PubMed ID: 23183194 [TBL] [Abstract][Full Text] [Related]
55. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]
56. Cardiac resynchronization therapy response in cardiac sarcoidosis. Shabtaie SA; Sehrawat O; Lee JZ; Cha YM; Mulpuru SK; Kowlgi NG; Siontis KC; Rosenbaum AN; Bois JP; AbouEzzeddine OF; Noseworthy PA; Asirvatham SJ; DeSimone CV; Deshmukh AJ J Cardiovasc Electrophysiol; 2022 Sep; 33(9):2072-2080. PubMed ID: 35870183 [TBL] [Abstract][Full Text] [Related]
57. [A multi-center study on the long-term mortality and related risk factors in patients with chronic heart failure receiving resynchronization therapy]. Qi SY; Wang DM; Yu HB; Ding C; Tian FL; Ru LS; Li J; Zhang B; Han YL Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):951-955. PubMed ID: 27903393 [No Abstract] [Full Text] [Related]
58. Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function. Looi KL; Gajendragadkar PR; Khan FZ; Elsik M; Begley DA; Fynn SP; Grace AA; Heck PM; Virdee M; Agarwal S Heart; 2014 May; 100(10):794-9. PubMed ID: 24691411 [TBL] [Abstract][Full Text] [Related]
59. Female gender is associated with a better outcome after cardiac resynchronization therapy. Leyva F; Foley PW; Chalil S; Irwin N; Smith RE Pacing Clin Electrophysiol; 2011 Jan; 34(1):82-8. PubMed ID: 21214589 [TBL] [Abstract][Full Text] [Related]